Clinical Trials Directory

Trials / Completed

CompletedNCT04678349

The Role of Partial Hydrolyzed Guar Gum in High Stoma Output Management Among Cancer Patients With Ileostomy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
29 (actual)
Sponsor
Universiti Putra Malaysia · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

this is a cross sectional intervention study to investigate the role of partial hydrolyzed guar gum in high stoma output management among cancer patients with ileostomy. This study hypotheses there is improvement in stoma output in PHGG if compare with control. There are two groups of subjects in this study. Conventional group (CG) will include retrospective historical data (those subjects with post-operative ileostomy) from Jan 2016 to June 2019. Intervention group (PHGG) will be subjects with ileostomy which involves prospective intervention by giving partial hydrolyzed guar gum upon start orally. Data on stoma output (volume \& consistency), length of hospital stay, readmission within 30-days discharged and dietary intake will be recorded in data collection form.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPHGGSubjects will be given 4 scoops (40g) PHGG, which provide 160kcal, 0.24g protein, 30.4g soluble fibre, 40g carbohydrate and 0g sugar, once allowed orally.
OTHERconventional carefollow low fibre diet and anti-diarrhea drugs

Timeline

Start date
2021-05-01
Primary completion
2021-09-28
Completion
2021-11-29
First posted
2020-12-21
Last updated
2022-11-04

Locations

1 site across 1 country: Malaysia

Source: ClinicalTrials.gov record NCT04678349. Inclusion in this directory is not an endorsement.

The Role of Partial Hydrolyzed Guar Gum in High Stoma Output Management Among Cancer Patients With Ileostomy (NCT04678349) · Clinical Trials Directory